- Home
- ARTW vs VRAX Comparison
ARTW vs VRAX Comparison
Compare ARTW & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- VRAX
- Stock Information
- Founded
- ARTW 1956
- VRAX 2013
- Country
- ARTW United States
- VRAX United Kingdom
- Employees
- ARTW N/A
- VRAX N/A
- Industry
- ARTW Industrial Machinery/Components
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ARTW Industrials
- VRAX Health Care
- Exchange
- ARTW Nasdaq
- VRAX Nasdaq
- Market Cap
- ARTW 7.8M
- VRAX 7.8M
- IPO Year
- ARTW N/A
- VRAX 2022
- Fundamental
- Price
- ARTW $1.53
- VRAX $2.37
- Analyst Decision
- ARTW
- VRAX
- Analyst Count
- ARTW 0
- VRAX 0
- Target Price
- ARTW N/A
- VRAX N/A
- AVG Volume (30 Days)
- ARTW 11.9K
- VRAX 198.4K
- Earning Date
- ARTW 10-04-2024
- VRAX 02-05-2025
- Dividend Yield
- ARTW N/A
- VRAX N/A
- EPS Growth
- ARTW N/A
- VRAX N/A
- EPS
- ARTW N/A
- VRAX N/A
- Revenue
- ARTW $25,181,639.00
- VRAX $84,872.00
- Revenue This Year
- ARTW N/A
- VRAX $5,169.18
- Revenue Next Year
- ARTW N/A
- VRAX $66.97
- P/E Ratio
- ARTW N/A
- VRAX N/A
- Revenue Growth
- ARTW N/A
- VRAX 7.03
- 52 Week Low
- ARTW $1.33
- VRAX $0.60
- 52 Week High
- ARTW $2.37
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- ARTW 36.54
- VRAX 64.60
- Support Level
- ARTW $1.49
- VRAX $1.51
- Resistance Level
- ARTW $1.59
- VRAX $1.98
- Average True Range (ATR)
- ARTW 0.06
- VRAX 0.18
- MACD
- ARTW -0.01
- VRAX 0.03
- Stochastic Oscillator
- ARTW 26.09
- VRAX 98.85
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.